Skip to main content
Clinical Trials/ACTRN12620000066987
ACTRN12620000066987
Completed
未知

Optimising the radiotherapy planning and treatment for anal cancer

Austin Health0 sites11 target enrollmentJanuary 28, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Austin Health
Enrollment
11
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 28, 2020
End Date
December 31, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria
  • Histologically confirmed SCC Anal Canal confined to the pelvis
  • ECOG Performance Status 0\-2
  • Age \> 18 yrs;
  • competent to give written informed consent

Exclusion Criteria

  • Contraindication to MRI such as
  • cochlear implants
  • some cardiac stents
  • claustrophobia
  • Allergy to Gadolinium (DCE scan)
  • Contraindication to PET such as
  • Poor renal function
  • Gross metastatic disease
  • Other illness that would impair ability to remain still/stable during treatment
  • Healing/bleeding disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials